# Arisan Therapeutics Inc.

Canonical: https://abierto.us/vendors/arisan-therapeutics-inc-pyrktqpnvjz8

- UEI: PYRKTQPNVJZ8
- CAGE: 616D2
- Location: Carlsbad, CA
- Awards in window: 2 (2 transactions), $2,933,547 obligated, January 20, 2026 to July 29, 2026

## Awarding agencies

- National Institutes of Health: 2 awards, $2,933,547

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $2,933,547

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75N93026C00012 (definitive contract): $2,933,547, National Institutes of Health Niaid. To Develop a Therapeutic Small Molecule Viral Entry Inhibitor as a Medical Countermeasure for Filovirus Infection.. https://www.usaspending.gov/award/CONT_AWD_75N93026C00012_7529_-NONE-_-NONE-/
- 75N93023C00051 (definitive contract): $0, National Institutes of Health Niaid. To Conduct Non-Clinical Good Laboratory Practice (Glp) in Vivo Genotoxicity and Reproductive Toxicology and GLP Development and Reproductive (Dart) Toxicology Studies.. https://www.usaspending.gov/award/CONT_AWD_75N93023C00051_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/arisan-therapeutics-inc-pyrktqpnvjz8.